J Clin Microbiol 2002, 40:10–15.PubMedCrossRef 6. Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ: An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol 2000, 17:13–22.PubMedCrossRef 7. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR: An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 1999, 341:929–935.PubMedCrossRef 8. Chang SC, Lin JY, Lo LY, Li ML, Shih SR: Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol 2004, 10:338–349.PubMedCrossRef 9. Liang CC, Sun MJ, Lei HY, Chen SH,
Yu CK, Liu CC, Wang JR, Yeh TM: Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. RAD001 supplier J Med Virol 2004, 74:597–603.PubMedCrossRef 10. Chen LC, Shyu HW, Chen SH, Lei HY, Yu CK, Yeh TM: Enterovirus
71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol 2006, 78:780–786.PubMedCrossRef 11. Lum LC, Wong MK-1775 mouse KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, AbuBakar S, Lambert M: Fatal enterovirus 71 encephalomyelitis. J Pediatr 1998, 133:795–798.PubMedCrossRef 12. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H: Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med Oxalosuccinic acid 2009, 15:794–797.PubMedCrossRef 13. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S: Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009, 15:798–801.PubMedCrossRef 14. Sears P, Wong CH: Enzyme
action in glycoprotein synthesis. Cell Mol Life Sci 1998, 54:223–252.PubMedCrossRef 15. Varki A: Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3:97–130.PubMedCrossRef 16. Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70:5282–5287.PubMed 17. Basu A, Kanda T, Beyene A, Saito K, Meyer K, Ray R: Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells. J Virol 2007, 81:3933–3941.PubMedCrossRef 18. Lee E, Pavy M, Young N, Freeman C, Lobigs M: Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res 2006, 69:31–38.PubMedCrossRef 19. Escribano-Romero E, Jimenez-Clavero MA, Gomes P, Garcia-Ranea JA, Ley V: Heparan sulphate mediates swine vesicular disease virus attachment to the host cell. J Gen Virol 2004, 85:653–663.PubMedCrossRef 20. Witvrouw M, De Clercq E: Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol 1997, 29:497–511.PubMedCrossRef 21.